ForteBio (United States)

Company in Fremont, United States
1 article (0.01 seconds)
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy - Nature Biotechnology
IL-2 cytokine therapy is made safer by splitting a designed mimetic in two for tumor targeting.
Science & Technology
www.nature.com